Pierre Dsy - 9342-8530 Qubec Consulting Pres

Insider

Pierre Dsy is Consulting Pres of 9342 8530 Qubec
Phone418-527-6100
Webhttp://www.diagnocure.com

9342-8530 Qubec Management Efficiency

The company has return on total asset (ROA) of 1.3432 % which means that it generated a profit of $1.3432 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2777 %, meaning that it generated $1.2777 on every $100 dollars invested by stockholders. 9342-8530 Qubec's management efficiency ratios could be used to measure how well 9342-8530 Qubec manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

INSIDER Age

Nir KorczakPlaytika Holding Corp
44
Yau MakTencent Music Entertainment
59
James MitchellTencent Music Entertainment
46
Gregg CoccariUdemy Inc
71
Brent IrvinTencent Music Entertainment
47
Devon SwansonUdemy Inc
N/A
TakWai WongTencent Music Entertainment
42
Cheuk YipTencent Music Entertainment
43
David NiedermanPlaytika Holding Corp
N/A
Robert AntokolPlaytika Holding Corp
56
Lugang HuaSkillful Craftsman Education
52
Shannon OkinakaUniversal Technical Institute
45
Robert BurnfieldUniversal Technical Institute
N/A
Troy VankePlaytika Holding Corp
N/A
Sonia MasonUniversal Technical Institute
44
Llibert ArgerichUdemy Inc
44
Linlin ChenTencent Music Entertainment
43
Christopher KevaneUniversal Technical Institute
50
Xiaofeng GaoSkillful Craftsman Education
53
Edith NganTencent Music Entertainment
55
Erez RachmilPlaytika Holding Corp
48
9342-8530 Qubec Inc., a life sciences company, develops and commercializes products relating to the diagnosis of cancer in Canada. The company was formerly known as DiagnoCure Inc. 9342-8530 Qubec Inc. was founded in 1994 and is headquartered in Quebec, Canada. Diagnocure is traded on OTC Exchange in the United States. 9342 8530 Qubec (DGCRF) is traded on OTCCE Exchange in USA and employs 3 people.

Management Performance

9342 8530 Qubec Leadership Team

Elected by the shareholders, the 9342-8530 Qubec's board of directors comprises two types of representatives: 9342-8530 Qubec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 9342-8530. The board's role is to monitor 9342-8530 Qubec's management team and ensure that shareholders' interests are well served. 9342-8530 Qubec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, 9342-8530 Qubec's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yves Fradet, Non-Independent Chairman of the Board and Presidentident, Chief Medical Officer
Andrew Sheldon, Director
Pierre Dsy, Consulting Pres
Pierre Lapalme, Advisor Pres

9342-8530 Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is 9342-8530 Qubec a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in 9342-8530 Stock

If you are still planning to invest in 9342 8530 Qubec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 9342-8530 Qubec's history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins